Clinical Trial Update: Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial [Phase 2]

View source ↗

Summary

Phase 2 ENLIGHT trial evaluating reduced radiation dose to the elective neck in HPV-associated oropharyngeal cancer (Stage I-II); currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv-associated Oropharyngeal Cancer

Snippet

Sponsor: Northwestern University | Conditions: Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Phase 2 | Status: NOT_YET_RECRUITING